Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0001470831-26-000812

President and COO sold 18,750 shares at $27.98 ($524,533)

  • President and COO acquired 18,750 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Cohlhepp Ryan · President and COO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-10 Exercise or conversion : show line 1 in the form 10b5-1 +18,750 $3.79 $71,059 200,391 D
2026-08-10 Sale : show line 2 in the form 10b5-1 −18,750 $27.98 $524,533 181,641 D
Open-market sales · 18,750 sh · avg $27.98 · $524,533

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-10 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −18,750 51,752 D
Loading xslF345X06/wk-form4_1786565947.xml…